Objective: To evaluate sex, age at diabetes onset, puberty, and HbA, with subjects followed from diabetes diagnosis and during different time periods, as risk factors for developing diabetic simplex and proliferative retinopathy.
Research Design And Methods: In a population-based observational study, HbA for 451 patients diagnosed with diabetes before 35 years of age during 1983-1987 in southeast Sweden was followed for up to 18-24 years from diagnosis. Long-term mean weighted HbA (wHbA) was calculated. Retinopathy was evaluated by fundus photography and analyzed in relation to wHbA levels.
Results: Lower wHbA, diabetes onset ≤5 years of age, and diabetes onset before puberty, but not sex, were associated with longer time to appearance of simplex retinopathy. Proliferative retinopathy was associated only with wHbA. The time to first appearance of any retinopathy decreased with increasing wHbA. Lower wHbA after ≤5 years' diabetes duration was associated with later onset of simplex retinopathy but not proliferative retinopathy. With time, most patients developed simplex retinopathy, except for those of the category wHbA ≤50 mmol/mol (6.7%), for which 20 of 36 patients were without any retinopathy at the end of the follow-up in contrast to none of 49 with wHbA >80 mmol/mol (9.5%).
Conclusions: Onset at ≤5 years of age and lower wHbA the first 5 years after diagnosis are associated with longer duration before development of simplex retinopathy. There is a strong positive association between long-term mean HbA measured from diagnosis and up to 20 years and appearance of both simplex and proliferative retinopathy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2337/dc18-1950 | DOI Listing |
Arch Virol
January 2025
Departamento de Biología, Bioquímica y Farmacia, Universidad Nacional del Sur-Bahía Blanca, Buenos Aires, Argentina.
Neurodegenerative pathologies such as age-related macular degeneration currently have no cure or effective treatment. In this type of disease, the presence of amyloid-β peptides, oxidative stress, and inflammation trigger dysregulation of retinal pigment epithelial cells and progression toward the death of these cells, resulting in a loss of vision. The production of amyloid-β peptides, oxidative stress, and inflammation can be triggered in response to viral infections.
View Article and Find Full Text PDFJ Fr Ophtalmol
December 2024
Service d'ophtalmologie, Sorbonne université, CHU Pitié-Salpêtrière, Paris, France.
Viruses belonging to the herpes family group, including HSV (herpes simplex virus) 1 and 2, VZV (varicella zoster virus) and CMV (cytomegalovirus) are the leading causes of necrotizing retinitis. These viral retinal necroses generally manifest in three forms, depending on the patient's immune status: acute retinal necrosis (ARN), progressive outer retinal necrosis (PORN) and CMV retinitis. Although specific, effective drug treatments are available today, early treatment initiation is essential to avoid sight-threatening complications.
View Article and Find Full Text PDFInt J Infect Dis
October 2024
Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Nankoku City, Kochi, Japan.
Rom J Ophthalmol
July 2024
Department of Ophthalmology, Moti Lal Nehru Medical College, Prayagraj, India.
Adv Neonatal Care
August 2024
School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran (Dr Tajalli and Mr Vafaee); and Neonatal Health Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran (Drs Safi, Navidi Moghaddam, and Fallahi).
Background: Acquired human cytomegalovirus (CMV) is a noteworthy disease in infants. This case study will highlight the influence of early diagnosis of CMV retinitis (CMVR) on avoid visual impairment.
Clinical Findings: We describe a preterm female infant with a birth weight of 2060 gr that was admitted for tracheostomy placement due to hypoxic-ischemic encephalopathy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!